Ferring

About Ferring

The Ferring product portfolio demonstrates an innovative and successful track record in the fields of Urology, Endocrine Oncology, Gastroenterology, Endocrinology (Growth) and Reproductive Health (Infertility and Obstetrics).

The common thread is that the Company remains focused on producing treatments that enable doctors to treat patients on the body's own terms.

Today Ferring has developed expertise and technologies that facilitate the use of these compounds, thus capitalising on our strength as a leading company in the field of peptide and protein chemistry.

Ferring Pharmaceuticals Contingency Supply

Ferring Pharmaceuticals are pleased to be able to provide a contingency supply service for the following products through CLARITYdtp:

▼DesmoMelt® desmopressin (as acetate) 120mg oral lyophilisate¹

▼DesmoMelt® desmopressin (as acetate) 240mg oral lyophilisate¹

▼DDAVPMelt® desmopressin (as acetate) 60mcg oral lyophilisate²

▼DDAVPMelt® desmopressin (as acetate) 120mcg oral lyophilisate²

▼DDAVPMelt® desmopressin (as acetate) 240mcg oral lyophilisate²

PENTASA® mesalazine 500mg Slow Release Tablets³

PENTASA® mesalazine 1g 100ml Enema⁴

PENTASA® mesalazine 1g Sachet⁵

PENTASA® mesalazine 2g Sachet⁵

PENTASA® mesalazine 1g Suppositories⁶

References

[1] ▼DesmoMelt® Summary of Product Characteristics
[2] ▼DDAVP® Melt Summary of Product Characteristics
[3] PENTASA® Tablets Summary of Product Characteristics
[4] PENTASA® Enema Summary of Product Characteristics
[5] PENTASA® Sachet Summary of Product Characteristics
[6] PENTASA® Suppositories Summary of Product Characteristics

If you are unable to view PDF documents, please download Adobe Acrobat Reader

Patient Information Leaflets

▼DesmoMelt®
Oral lyophilisates, desmopressin (as acetate)
▼DesmoMelt® Patient Information Leaflet
▼DesmoMelt® Summary of Product Characteristics 

▼DDAVP® Melt
Oral Lyophilisates, desmopressin (as acetate)
▼DDAVP® Melt Patient Information Leaflet
▼DDAVP® Melt Summary of Product Characteristics 

PENTASA®
Mesalazine
PENTASA® Tablets Patient Information Leaflet
PENTASA® Tablets Summary of Product Characteristics
PENTASA® Enema Patient Information Leaflet
PENTASA® Enema Summary of Product Characteristics
PENTASA® Sachet 1g Patient Information Leaflet
PENTASA® Sachet 1g Summary of Product Characteristics
PENTASA® Sachet 2g Patient Information Leaflet
PENTASA® Sachet 2g Summary of Product Characteristics
PENTASA® Suppositories Patient Information Leaflet
PENTASA® Suppositories Summary of Product Characteristics

Contact Ferring

Ferring Pharmaceuticals Ltd
Drayton Hall
Church Road
West Drayton
UB7 7PS

Adverse Events

Adverse Events should be reported. Reporting forms and information can be found at www.yellowcard.gov.uk

Adverse events should also be reported to Medical Information, Ferring Pharmaceuticals Ltd. 
Phone: +44 (0) 1753 214800.  Email: medical@ferring.com